Otsuka

6y

Statement Regarding Job Recruiting Fraud Scams Job postings, job offers, or introductions to enter into a business relationship with Otsuka through a third-party vendor may be unauthorized. Avoid being the subject of a scam by dealing only directly with Otsuka through its official Otsuka Career website (http://glassdoor.com/slink.htm?key=vMckD). Any authorized third-party vendor job boards should redirect any inquiry to this Otsuka Career website.

Otsuka

7y

Otsuka Pharmaceutical to Sponsor 30th Southeast Asian Games 2019 (Philippines)

Otsuka

7y

Otsuka and Click Therapeutics Collaborate to Develop and Commercialize Digital Therapeutics for Patients with Major Depressive Disorder

Otsuka

7y

Data Demonstrate Safety and Efficacy of Brexpiprazole in Patients with Schizophrenia Experiencing Severe Psychotic Symptoms

Otsuka

7y

Otsuka and Patrick J. Kennedy Lead Policy Forum Celebrating 10th Anniversary of Mental Health Parity and Addiction Equity Act

Otsuka

7y

Otsuka Pharmaceutical Development & Commercialization, Inc. Hosts Roundtable on Healthcare and Technology with U.S. Representative Bonnie Watson Coleman

Otsuka

7y

Otsuka Announces First Collaboration Agreement to Bring the ABILIFY MYCITE® System to the US Market

Otsuka

7y

Otsuka Pharmaceutical to Acquire Visterra

Otsuka

7y

Otsuka and Lundbeck's Rxulti® (brexpiprazole) approved by the European Commission. Rxulti® (brexpiprazole) has been approved for the treatment of schizophrenia in adults.

Otsuka

8y

Otsuka and Lundbeck to Start Third Phase 3 Trial in June to Evaluate Brexpiprazole in the Treatment of Agitation in Patients with Alzheimer's Disease